Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: experience of an outbreak in Sakai City, 1996.
Presented is a study of 15 patients (seven males and eight females ranging between 5 and 10 years of age) with hemolytic uremic syndrome (HUS) associated with hemorrhagic colitis that was caused by enterohemorrhagic Escherichia coli (EHEC) O157:H7, encountered during the outbreak in Sakai City in July, 1996. The complete form of HUS, which includes the three characteristics hemolytic anemia, thrombocytopenia and acute renal dysfunction, was noted in eight patients, while an incomplete form of HUS, which did not include all three characteristics, was noted in seven patients. Regarding treatment, intravenous gamma-globulin was administered in nine patients and dialysis was performed in five patients (two males and three females) with the complete form of HUS. In three of these five patients, plasma exchange was also performed. Weaning from dialysis was accomplished by the 15th day of disease in all patients. Some patients developed pancreatitis, central nervous system symptoms, fundal hemorrhage and elevation of transaminase, although these abnormalities subsided uneventfully. Renal biopsy, which was performed in two patients who recovered from acute renal failure but still had mild proteinuria and a decrease in creatinine clearance, showed moderate changes in the glomeruli and tubulointerstitium. One year after onset of disease, hematological and urological findings were within normal limits in all patients except one with the complete form of HUS, who still had slightly decreased creatinine clearance.
Yoshioka
K
K
Department of Pediatrics, Kinki University School of Medicine, Osaka, Japan. kzyoshio@med.kindai.ac.jp
Yagi
K
K
Moriguchi
N
N
D002648:Child; D003092:Colitis / Q000188:drug therapy / Q000382:microbiology*; D004196:Disease Outbreaks; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000453:epidemiology; D019453:Escherichia coli O157 / Q000472:pathogenicity*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000453:epidemiology; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007564:Japan / Q000453:epidemiology; D007674:Kidney Diseases / Q000209:etiology / Q000473:pathology; D008297:Male; D010951:Plasma Exchange; D006435:Renal Dialysis; D016896:Treatment Outcome; D005719:gamma-Globulins / Q000627:therapeutic use
D005719:gamma-Globulins